Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1617

1.

Population Pharmacokinetic-Pharmacodynamic Modeling of a Novel Methylphenidate Extended-Release Orally Disintegrating Tablet in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder.

Teuscher NS, Sikes CR, McMahen R, Engelking D.

J Clin Psychopharmacol. 2018 Oct;38(5):467-474. doi: 10.1097/JCP.0000000000000944.

PMID:
30119076
2.

Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder.

Sudnawa KK, Chirdkiatgumchai V, Ruangdaraganon N, Khongkhatithum C, Udomsubpayakul U, Jirayucharoensak S, Israsena P.

Pediatr Int. 2018 Sep;60(9):828-834. doi: 10.1111/ped.13641. Epub 2018 Sep 5.

PMID:
29931709
3.

Efficacy of Hippotherapy Versus Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.

Oh Y, Joung YS, Jang B, Yoo JH, Song J, Kim J, Kim K, Kim S, Lee J, Shin HY, Kwon JY, Kim YH, Jeong B.

J Altern Complement Med. 2018 May;24(5):463-471. doi: 10.1089/acm.2017.0358. Epub 2018 Apr 11.

PMID:
29641212
4.

QTc prolongation after ADHD medication.

Snircova E, Marcincakova Husarova V, Ondrejka I, Hrtanek I, Farsky I, Nosalova G.

Neuro Endocrinol Lett. 2018 Feb;38(8):549-554.

PMID:
29504733
5.

Does the efficacy of parent-child training depend on maternal symptom improvement? Results from a randomized controlled trial on children and mothers both affected by attention-deficit/hyperactivity disorder (ADHD).

Häge A, Alm B, Banaschewski T, Becker K, Colla M, Freitag C, Geissler J, von Gontard A, Graf E, Haack-Dees B, Hänig S, Hennighausen K, Hohmann S, Jacob C, Jaite C, Jennen-Steinmetz C, Kappel V, Matthies S, Philipsen A, Poustka L, Retz W, Rösler M, Schneider-Momm K, Sobanski E, Vloet TD, Warnke A, Jans T.

Eur Child Adolesc Psychiatry. 2018 Aug;27(8):1011-1021. doi: 10.1007/s00787-018-1109-0. Epub 2018 Jan 23.

PMID:
29362929
6.

Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol.

Atkins C, Fordham R, Clark AB, Stockl A, Jones AP, Wilson AM.

BMJ Open. 2017 Dec 4;7(12):e018532. doi: 10.1136/bmjopen-2017-018532.

7.

A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study).

Hegerl U, Mergl R, Sander C, Dietzel J, Bitter I, Demyttenaere K, Gusmão R, González-Pinto A, Zorrilla I, Alocén AG, Sola VP, Vieta E, Juckel G, Zimmermann US, Bauer M, Sienaert P, Quintão S, Edel MA, Bolyos C, Ayuso-Mateos JL, López-García P, Kluge M.

Eur Neuropsychopharmacol. 2018 Jan;28(1):185-194. doi: 10.1016/j.euroneuro.2017.11.003. Epub 2017 Nov 23.

PMID:
29174864
8.

Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.

Pliszka SR, Wilens TE, Bostrom S, Arnold VK, Marraffino A, Cutler AJ, López FA, DeSousa NJ, Sallee FR, Incledon B, Newcorn JH.

J Child Adolesc Psychopharmacol. 2017 Aug;27(6):474-482. doi: 10.1089/cap.2017.0084. Epub 2017 Jul 21.

9.

Methylphenidate alters brain connectivity after enhanced physical performance.

King M, van Breda K, Rauch LH, Brooks SJ, Stein DJ, Ipser J.

Brain Res. 2018 Jan 15;1679:26-32. doi: 10.1016/j.brainres.2017.10.026. Epub 2017 Oct 28.

PMID:
29107662
10.

Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.

Adams J, Alipio-Jocson V, Inoyama K, Bartlett V, Sandhu S, Oso J, Barry JJ, Loring DW, Meador KJ.

Epilepsia. 2017 Dec;58(12):2124-2132. doi: 10.1111/epi.13917. Epub 2017 Oct 9.

11.

Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.

Padala PR, Padala KP, Lensing SY, Ramirez D, Monga V, Bopp MM, Roberson PK, Dennis RA, Petty F, Sullivan DH, Burke WJ.

Am J Psychiatry. 2018 Feb 1;175(2):159-168. doi: 10.1176/appi.ajp.2017.17030316. Epub 2017 Sep 15.

PMID:
28945120
12.

Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder.

Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L.

Psychiatry Res Neuroimaging. 2017 Nov 30;269:36-42. doi: 10.1016/j.pscychresns.2017.09.009. Epub 2017 Sep 12.

PMID:
28938219
13.

The effect of single-dose methylphenidate on the rate of error-driven learning in healthy males: a randomized controlled trial.

Howlett JR, Huang H, Hysek CM, Paulus MP.

Psychopharmacology (Berl). 2017 Nov;234(22):3353-3360. doi: 10.1007/s00213-017-4723-5. Epub 2017 Sep 1.

14.

Increased default-mode variability is related to reduced task-performance and is evident in adults with ADHD.

Mowinckel AM, Alnæs D, Pedersen ML, Ziegler S, Fredriksen M, Kaufmann T, Sonuga-Barke E, Endestad T, Westlye LT, Biele G.

Neuroimage Clin. 2017 Mar 30;16:369-382. doi: 10.1016/j.nicl.2017.03.008. eCollection 2017.

15.

A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression.

Masi G, Manfredi A, Nieri G, Muratori P, Pfanner C, Milone A.

J Clin Psychopharmacol. 2017 Oct;37(5):590-594. doi: 10.1097/JCP.0000000000000747.

PMID:
28806385
16.

Verbal working memory-related functional connectivity alterations in boys with attention-deficit/hyperactivity disorder and the effects of methylphenidate.

Wu ZM, Bralten J, An L, Cao QJ, Cao XH, Sun L, Liu L, Yang L, Mennes M, Zang YF, Franke B, Hoogman M, Wang YF.

J Psychopharmacol. 2017 Aug;31(8):1061-1069. doi: 10.1177/0269881117715607. Epub 2017 Jun 28.

PMID:
28656805
17.

Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.

Schulz KP, Bédard AV, Fan J, Hildebrandt TB, Stein MA, Ivanov I, Halperin JM, Newcorn JH.

J Am Acad Child Adolesc Psychiatry. 2017 Jul;56(7):602-609.e2. doi: 10.1016/j.jaac.2017.04.005. Epub 2017 May 10.

PMID:
28647012
18.

Efficacy of methylphenidate for the treatment of mental sequelae after traumatic brain injury.

Zhang WT, Wang YF.

Medicine (Baltimore). 2017 Jun;96(25):e6960. doi: 10.1097/MD.0000000000006960.

19.

Effects of monoaminergic drugs on training-induced motor cortex plasticity in older adults.

Kesar TM, Belagaje SR, Pergami P, Haut MW, Hobbs G, Buetefisch CM.

Brain Res. 2017 Sep 1;1670:106-117. doi: 10.1016/j.brainres.2017.06.015. Epub 2017 Jun 17.

20.

The Effects of Methylphenidate on the Neural Signatures of Sustained Attention.

Dockree PM, Barnes JJ, Matthews N, Dean AJ, Abe R, Nandam LS, Kelly SP, Bellgrove MA, O'Connell RG.

Biol Psychiatry. 2017 Nov 1;82(9):687-694. doi: 10.1016/j.biopsych.2017.04.016. Epub 2017 May 10.

PMID:
28599833

Supplemental Content

Loading ...
Support Center